MARSH HOUSE MEDICAL PRACTICE — All Prescriptions & Medications — Page 11
Practice Code: A81040 | BILLINGHAM, TS23 2DG
Showing results 501-550 of 595
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Oral rehydration salts | 17 | 189 | £71 | -41.2% ▼ |
| Powder thickener - starch based (0913161) | 17 | 7,425 | £208 | +18.4% ▲ |
| Travoprost | 17 | 85 | £54 | -63.9% ▼ |
| Aluminium chloride | 17 | 710 | £64 | +109.7% ▲ |
| 17 | 278 | £617 | +24.6% ▲ | |
| 17 | 240 | £265 | -78.0% ▼ | |
| Naftidrofuryl oxalate | 16 | 1,932 | £218 | -50.9% ▼ |
| Rimegepant | 16 | 229 | £3.0K | +63.1% ▲ |
| Zonisamide | 16 | 1,792 | £2.0K | -63.3% ▼ |
| Other compound vitamin/mineral formulation preparations | 16 | 514 | £52 | -50.1% ▼ |
| Atropine sulfate | 16 | 420 | £345 | +25.6% ▲ |
| Zinc oxide | 16 | 1,020 | £54 | -20.4% ▼ |
| Benzoyl peroxide | 16 | 690 | £120 | +13.5% ▲ |
| Silver sulfadiazine | 16 | 3,150 | £137 | +301.0% ▲ |
| 16 | 176 | £164 | -50.6% ▼ | |
| 16 | 223 | £78 | +34.2% ▲ | |
| 16 | 250 | £994 | -42.5% ▼ | |
| 16 | 44 | £449 | -48.4% ▼ | |
| 16 | 620 | £2.5K | +138.6% ▲ | |
| Telmisartan | 15 | 420 | £60 | -74.1% ▼ |
| Perampanel | 15 | 448 | £2.1K | -30.8% ▼ |
| Trihexyphenidyl hydrochloride | 15 | 476 | £34 | -47.1% ▼ |
| Combined ethinylestradiol 35mcg | 15 | 1,617 | £114 | +20.4% ▲ |
| Potassium chloride | 15 | 320 | £32 | -19.8% ▼ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 15 | 9,120 | £142 | -34.5% ▼ |
| Betamethasone sodium phosphate | 15 | 190 | £42 | -42.1% ▼ |
| 15 | 2,100 | £292 | -52.8% ▼ | |
| 15 | 690 | £2.7K | -42.0% ▼ | |
| Sennosides | 14 | 5,550 | £103 | -54.7% ▼ |
| Brivaracetam | 14 | 784 | £1.8K | -58.8% ▼ |
| Water for injection | 14 | 185 | £93 | -58.6% ▼ |
| Ergocalciferol | 14 | 720 | £96 | -16.4% ▼ |
| Tablets OTC glucose for diabetic hypo treatment (0913541) | 14 | 392 | £13 | -6.8% ▼ |
| Ipratropium bromide | 14 | 14 | £102 | -13.7% ▼ |
| Heparinoid | 14 | 700 | £53 | +7.4% ▲ |
| 14 | 90 | £11 | -51.7% ▼ | |
| Glycopyrronium bromide | 13 | 2,050 | £1.5K | -36.7% ▼ |
| Budesonide | 13 | 1,236 | £4.7K | -17.0% ▼ |
| Inclisiran | 13 | 13 | £710 | +3.2% ▲ |
| Alimemazine tartrate | 13 | 364 | £962 | +0.5% vs avg |
| Midazolam hydrochloride | 13 | 48 | £1.1K | -9.8% ▼ |
| Entacapone | 13 | 1,456 | £304 | -14.7% ▼ |
| Dapsone | 13 | 364 | £87 | +25.8% ▲ |
| Repaglinide | 13 | 1,170 | £109 | -46.2% ▼ |
| Raloxifene hydrochloride | 13 | 364 | £53 | -12.0% ▼ |
| Solifenacin/tamsulosin | 13 | 390 | £341 | -36.7% ▼ |
| Pyridoxine hydrochloride | 13 | 1,820 | £747 | -39.5% ▼ |
| Ascorbic acid | 13 | 364 | £444 | -36.7% ▼ |
| Etoricoxib | 13 | 616 | £168 | -83.9% ▼ |
| Tizanidine hydrochloride | 13 | 2,938 | £487 | -50.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.